tiprankstipranks
The Fly

Abbott announces Lingo CGM system available in U.S.

Abbott announces Lingo CGM system available in U.S.

Abbott announced U.S. availability of Lingo, the company’s first continuous glucose monitoring system available without a prescription. The Lingo system includes a biosensor and a mobile app designed for consumers who want to improve their overall health and wellness. Lingo is based on Abbott’s world-leading FreeStyle Libre continuous glucose monitoring technology, now used by more than 6 million people with diabetes globally.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com